Filetti, M.; Occhipinti, M.; Cirillo, A.; Scirocchi, F.; Ugolini, A.; Giusti, R.; Lombardi, P.; Daniele, G.; Botticelli, A.; Lo Russo, G.;
et al. Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature. Cancers 2024, 16, 3955.
https://doi.org/10.3390/cancers16233955
AMA Style
Filetti M, Occhipinti M, Cirillo A, Scirocchi F, Ugolini A, Giusti R, Lombardi P, Daniele G, Botticelli A, Lo Russo G,
et al. Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature. Cancers. 2024; 16(23):3955.
https://doi.org/10.3390/cancers16233955
Chicago/Turabian Style
Filetti, Marco, Mario Occhipinti, Alessio Cirillo, Fabio Scirocchi, Alessio Ugolini, Raffaele Giusti, Pasquale Lombardi, Gennaro Daniele, Andrea Botticelli, Giuseppe Lo Russo,
and et al. 2024. "Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature" Cancers 16, no. 23: 3955.
https://doi.org/10.3390/cancers16233955
APA Style
Filetti, M., Occhipinti, M., Cirillo, A., Scirocchi, F., Ugolini, A., Giusti, R., Lombardi, P., Daniele, G., Botticelli, A., Lo Russo, G., De Braud, F., Marchetti, P., Nuti, M., Ferretti, E., Farina, L., Rughetti, A., & Petti, M.
(2024). Exploring Genomic Biomarkers for Pembrolizumab Response: A Real-World Approach and Patient Similarity Network Analysis Reveal DNA Response and Repair Gene Mutations as a Signature. Cancers, 16(23), 3955.
https://doi.org/10.3390/cancers16233955
